PI3Kd inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax. (2020)

First Author: Serrat N
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2020001584

PubMed Identifier: 32898249

Publication URI: http://europepmc.org/abstract/MED/32898249

Type: Journal Article/Review

Volume: 4

Parent Publication: Blood advances

Issue: 17

ISSN: 2473-9529